Anhui Biochem Pharmaceutical

Anhui Biochem Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale production of antiviral medications, particularly for HIV/AIDS and Hepatitis B. The company is a major global supplier of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, maintaining significant manufacturing facilities that comply with international GMP standards. Their product portfolio includes essential generic antivirals such as Lamivudine, Tenofovir, and Entecavir, which are distributed through domestic healthcare systems and international procurement programs. Anhui Biochem plays a critical role in China's national drug innovation projects and has expanded its capabilities to include treatments for COVID-19. The firm is recognized for its integrated industrial chain, spanning from intermediate synthesis to final drug formulation.